ESPR logo

Esperion Therapeutics (ESPR) Operating Expenses

Annual Operating Expenses

$228.63 M
+$621.00 K+0.27%

31 December 2023

ESPR Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$50.37 M
-$5.27 M-9.48%

30 September 2024

ESPR Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ESPR Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.3%+4.7%
3 y3 years-34.0%-22.0%
5 y5 years+11.8%-24.5%

ESPR Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-34.0%+0.3%-23.6%+4.7%
5 y5 years-34.0%+11.8%-51.3%+4.7%
alltimeall time-34.0%+2149.3%-51.3%+2231.7%

Esperion Therapeutics Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$50.37 M(-9.5%)
June 2024
-
$55.65 M(+0.5%)
Mar 2024
-
$55.39 M(-12.3%)
Dec 2023
$228.63 M(+0.3%)
$63.16 M(+31.3%)
Sept 2023
-
$48.13 M(-14.2%)
June 2023
-
$56.06 M(-8.5%)
Mar 2023
-
$61.28 M(+7.2%)
Dec 2022
$228.01 M(-21.6%)
$57.17 M(+5.7%)
Sept 2022
-
$54.10 M(-12.8%)
June 2022
-
$62.04 M(+13.4%)
Mar 2022
-
$54.70 M(-17.1%)
Dec 2021
$290.96 M(-16.0%)
$65.95 M(+2.1%)
Sept 2021
-
$64.60 M(-9.5%)
June 2021
-
$71.39 M(-19.8%)
Mar 2021
-
$89.02 M(-14.0%)
Dec 2020
$346.55 M(+43.5%)
$103.52 M(+23.1%)
Sept 2020
-
$84.11 M(+1.7%)
June 2020
-
$82.67 M(+8.4%)
Mar 2020
-
$76.25 M(+27.2%)
Dec 2019
$241.47 M(+18.0%)
$59.95 M(-10.2%)
Sept 2019
-
$66.75 M(+18.6%)
June 2019
-
$56.28 M(-3.8%)
Mar 2019
-
$58.49 M(-3.6%)
Dec 2018
$204.59 M(+21.1%)
$60.65 M(+19.9%)
Sept 2018
-
$50.56 M(+8.8%)
June 2018
-
$46.48 M(-0.9%)
Mar 2018
-
$46.89 M(+21.2%)
Dec 2017
$168.98 M
$38.70 M(-15.4%)
DateAnnualQuarterly
Sept 2017
-
$45.74 M(+4.8%)
June 2017
-
$43.66 M(+6.8%)
Mar 2017
-
$40.89 M(+39.6%)
Dec 2016
$76.15 M(+52.2%)
$29.29 M(+65.3%)
Sept 2016
-
$17.71 M(+23.6%)
June 2016
-
$14.33 M(-3.3%)
Mar 2016
-
$14.82 M(+12.0%)
Dec 2015
$50.04 M(+38.1%)
$13.23 M(+2.4%)
Sept 2015
-
$12.92 M(+3.7%)
June 2015
-
$12.46 M(+9.1%)
Mar 2015
-
$11.43 M(+21.8%)
Dec 2014
$36.22 M(+59.2%)
$9.38 M(-3.3%)
Sept 2014
-
$9.70 M(+4.8%)
June 2014
-
$9.25 M(+17.3%)
Mar 2014
-
$7.89 M(-19.0%)
Dec 2013
$22.76 M(+123.0%)
$9.74 M(+80.1%)
Sept 2013
-
$5.41 M(+26.6%)
June 2013
-
$4.27 M(+27.8%)
Mar 2013
-
$3.34 M(+54.8%)
Dec 2012
$10.20 M(+0.4%)
$2.16 M(-27.8%)
Sept 2012
-
$2.99 M(+4.4%)
June 2012
-
$2.86 M(+30.8%)
Mar 2012
-
$2.19 M
Dec 2011
$10.16 M(-65.2%)
-
Dec 2002
$29.24 M(-0.3%)
-
Dec 2001
$29.33 M(+9.5%)
-
Dec 2000
$26.79 M(+129.3%)
-
Dec 1999
$11.69 M
-

FAQ

  • What is Esperion Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Esperion Therapeutics?
  • What is Esperion Therapeutics annual operating expenses year-on-year change?
  • What is Esperion Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Esperion Therapeutics?
  • What is Esperion Therapeutics quarterly operating expenses year-on-year change?

What is Esperion Therapeutics annual total operating expenses?

The current annual operating expenses of ESPR is $228.63 M

What is the all time high annual operating expenses for Esperion Therapeutics?

Esperion Therapeutics all-time high annual total operating expenses is $346.55 M

What is Esperion Therapeutics annual operating expenses year-on-year change?

Over the past year, ESPR annual total operating expenses has changed by +$621.00 K (+0.27%)

What is Esperion Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of ESPR is $50.37 M

What is the all time high quarterly operating expenses for Esperion Therapeutics?

Esperion Therapeutics all-time high quarterly total operating expenses is $103.52 M

What is Esperion Therapeutics quarterly operating expenses year-on-year change?

Over the past year, ESPR quarterly total operating expenses has changed by +$2.25 M (+4.67%)